Leveraging Robotics to Deliver Minimally Invasive Care to Heart Valve Patients: Our Investment in Capstan Medical

The Eclipse team is excited to lead Capstan’s $31.4M Series B to accelerate its mission to bring the benefits of robotics to one of the few remaining untouched areas of medicine, structural heart.